Lev El Diagnostic

Company Overview

Snapshot

Founded in January 2013 by Jacob Levitan, Lev El Diagnostic operates with 1–10 employees. The company focuses on developing non-invasive solutions for cardiovascular disease detection. In November 2019, a multi-center clinical study demonstrated that its HeartTrends product improved early detection for heart disease in healthy individuals.

Business overview

Lev El Diagnostic is a medical technology company specializing in the non-invasive detection of cardiovascular diseases. Its core product, HeartTrends, is a software solution that analyzes R-R interval measurements from off-the-shelf Holter monitors to assist in the early detection of myocardial ischemia related to coronary artery disease (CAD). The company serves the digital healthcare sector, providing diagnostic tools for doctors, hospitals, clinics, and insurance companies globally, with a focus on Israel and the United Kingdom.

Strategic signal

In November 2019, a multi-center clinical study validated the effectiveness of Lev El Diagnostic's HeartTrends product in improving the early detection of heart disease in healthy individuals. This clinical validation provides a strong signal of the product's potential for widespread adoption in preventative cardiology and strengthens its position as a viable alternative to traditional cardiac stress tests, indicating significant market potential for non-invasive diagnostic solutions.

Company Intelligence Q&A

What is the primary product offered by Lev El Diagnostic?

Lev El Diagnostic offers HeartTrends, a software solution designed for the non-invasive detection of cardiovascular diseases, specifically myocardial ischemia related to coronary artery disease.

When was Lev El Diagnostic founded?

Lev El Diagnostic was founded in January 2013.

What was a significant development for HeartTrends in November 2019?

In November 2019, a multi-center clinical study demonstrated that HeartTrends improved early detection for heart disease in healthy individuals.

What skepticism was raised about the company's algorithm in December 2019?

In December 2019, an article in MedCity News reported that a doctor expressed skepticism regarding the company's claim that its algorithm identifies a new risk factor for heart disease.

What claim did the company make about its detection method in April 2015?

In April 2015, Lev El Diagnostic announced that its breakthrough test for early detection of coronary artery disease was superior to exercise stress testing.